Seroquel XR Needs Long-Term Safety Data For Depression, Anxiety Monotherapy – FDA Panel
This article was originally published in The Pink Sheet Daily
Executive Summary
AstraZeneca does gets recommendation for the atypical antipsychotic as adjunct therapy in major depressive disorder.